Press Release
Category Added in a WPeMatico Campaign
-
MarketersMEDIA Newswire29 January 2026
LLM.co Launches Private LLM Infrastructure Purpose-Built for Cybersecurity Teams
New offering enables CISOs, security teams, and MSSPs to deploy AI for threat analysis, incident response, and compliance—without exposing sensitive…
Read More » -
Cision PR Newswire29 January 2026
FPT announces the establishment of an Advanced Semiconductor Testing and Packaging plant, accelerating the integration of Vietnam’s Semiconductor value chain
FPT Signs Key International Agreements to Advance Vietnam’s Mastery of Semiconductor Technology HANOI, Vietnam, Jan. 29, 2026 /PRNewswire/ — On…
Read More » -
MarketersMEDIA Newswire29 January 2026
Self Learners Announces New Approach to Self Directed Learning for Professionals in the AI Age
Self Learners, a self-directed learning platform founded by Diego Vera, unveils an innovative learning methodology designed to help professionals stay…
Read More » -
Business Wire29 January 2026
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™
U.S. FDA Approves YUVEZZI™ as the only dual-agent, once daily presbyopia-correcting eye drop LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a…
Read More » -
Cision PR Newswire29 January 2026
Bybit Leads Global XAUT Spot Trading with ~16% Market Share as Tokenized Gold Rallies to New Highs
DUBAI, UAE, Jan. 28, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announced that it has…
Read More » -
Cision PR Newswire29 January 2026
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
SHANGHAI, Jan. 28, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and…
Read More » -
Business Wire29 January 2026
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally designed to deliver durability,…
Read More » -
Cision PR Newswire29 January 2026
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
SHANGHAI, Jan. 28, 2026 /PRNewswire/ — QureBio Ltd., a clinical-stage biotech company focusing on development of bispecific antibodies and other…
Read More » -
Cision PR Newswire29 January 2026
LG Energy Solution Releases 2025 Financial Results
LG Energy Solution posts KRW 23.7 trillion in consolidated revenue and KRW 1.3 trillion in operating profit in 2025 Company…
Read More » -
Cision PR Newswire29 January 2026
AI Is Reshaping National Power, but America’s Real Bottleneck Is Not Chips — It Is Electricity
GFM’s AI & Energy Research Brings “The Power Grid as National Power” into U.S. Technology, Energy, and National Security Discourse…
Read More »




